Highlights include clinical data from Phase 3 studies in Community Acquired Pneumonia (CABP) and microbiologic data from a Phase 2 study in ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to ...

The ongoing trial compares Pirfenidone 1,800 mg/day (600 mg tid) with placebo over a 52-week double-blind treatment period. Primary Endpoint: Change from baseline in forced vital capacity (FVC) % ...

Biotech investing is often a high-risk, high-reward game, with clinical trial results capable of sending stocks soaring or ...